EP4054584
METHODS OF TREATMENT AND/OR PREVENTION OF MAJOR ADVERSE CARDIOVASCULAR EVENTS (MACE) WITH A COMBINATION OF A BET BROMODOMAIN INHIBITOR AND A SODIUM DEPENDENT GLUCOSE TRANSPORT 2 INHIBITOR
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
4.11.2020EP published:
9.7.2025EP application number:
20884269.0
EPO information:
European Patent Register
Max expiry date:
3.11.2040
Title in English:
METHODS OF TREATMENT AND/OR PREVENTION OF MAJOR ADVERSE CARDIOVASCULAR EVENTS (MACE) WITH A COMBINATION OF A BET BROMODOMAIN INHIBITOR AND A SODIUM DEPENDENT GLUCOSE TRANSPORT 2 INHIBITORLanguage of the patent:
English
Timeline
Today
4.11.2020EP application
9.7.2025EP Publication
Owner
Name:
Resverlogix Corp.Address:
300, 4820 Richard Road SW, Calgary, AB T3E 6L1, CA
Inventor
Name:
LEBIODA, Kenneth EugeneAddress:
Calgary, AB T3Z 3T2, CA
Name:
HALLIDAY, Christopher Ross ArmstrongAddress:
Calgary, AB T2G 5P9, CA
Name:
KHAN, Aziz NaeemAddress:
Calgary, AB T3E 7M7, CA
Priority
Number:
201962930860 PDate:
5.11.2019Country:
US
Classification
Categories:
A61K 31/517, A61P 9/00, C07D 239/91, A61K 31/70, A61K 31/7042, A61K 31/7048, A61K 45/06